 LA JOLLA, Calif., May 3, 2021 PRNewswire -- Avidity Biosciences, Inc. Nasdaq: RNA, a biopharmaceutical company pioneering a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates AOCsTM, today announced that it will host a virtual investor and analyst event focused on the companys AOC platform on Wednesday, May 19, 2021, from 8:00 a.m. 